CORTISOL-INDUCED INSULIN RESISTANCE IN MAN - IMPAIRED SUPPRESSION OF GLUCOSE-PRODUCTION AND STIMULATION OF GLUCOSE-UTILIZATION DUE TO A POSTRECEPTOR DEFECT OF INSULIN ACTION
CORTISOL-INDUCED INSULIN RESISTANCE IN MAN - IMPAIRED SUPPRESSION OF GLUCOSE-PRODUCTION AND STIMULATION OF GLUCOSE-UTILIZATION DUE TO A POSTRECEPTOR DEFECT OF INSULIN ACTION
复制标题
DOI:
10.1210/jcem-54-1-131
复制
发表时间:
1982-01-01
影响因子:
5.8
通讯作者:
GERICH, JE
中科院分区:
文献类型:
--
作者:
RIZZA, RA;MANDARINO, LJ;GERICH, JE
The present studies assessed the mechanisms responsible for cortisol-induced insulin resistance in man. The insulin dose-response characteristics for suppression of glucose production and stimulation of glucose utilization and their relationship to monocyte and erythrocyte insulin receptor binding were determined in 6 normal volunteers after 24-h infusion of cortisol and 24-h infusion of saline. The infusion of cortisol (2 .mu.g kg-1 min-1) increased the plasma cortisol concentration approximately 4-fold (37 .+-. 3 vs. 14 .+-. 1 .mu.g/dl; P < 0.01) to values observed during moderately severe stress in man. This hypercortisolemia increased postabsorptive plasma glucose (126 .+-. 2 vs. 97 .+-. 2 mg/dl; P < 0.01) and plasma insulin (16 .+-. 2 vs. 10 .+-. 2 .mu.U/ml; P < 0.01) concentrations and rates of glucose production (2.4 .+-. 0.1 vs. 2.1 .+-. -0.1 mg kg-1 min-1; P < 0.01) and utilization (2.5 .+-. 0.1 vs. 2.1 .+-. 0.1 mg kg-1 min-1; P < 0.01). Insulin dose-response curves for both suppression of glucose production (half-maximal response at 81 .+-. 19 vs. 31 .+-. 5 .mu.U/ml; P < 0.05) and stimulation of glucose utilization (half-maximal response at 104 .+-. 9 vs. 64 .+-. 7 .mu.U/ml; P < 0.01) were shifted to the right, with preservation of normal maximal responses to insulin. Neither monocyte nor erythrocyte insulin binding was decreased. Except at near-maximal insulin receptor occupancy, the action of insulin on glucose production and utilization per number of monocyte and erythrocyte insulin receptors occupied was decreased. Evidently the cortisol-induced insulin resistance in man is due to a decrease in both hepatic and extrahepatic sensitivity to insulin. Assuming that insulin binding to monocytes and erythrocytes reflects insulin binding in insulin-sensitive tissues, this decrease in insulin action can be explained on the basis of a postreceptor defect.